Phio Pharmaceuticals Advances in Cancer Trial and Increases Dose

Tuesday, 28 May 2024, 16:32
The latest development in the Phio Pharmaceuticals cancer trial has seen the company moving to the next dose level, signaling progress in the study. With this advancement, there is growing anticipation surrounding the potential impact of the increased dosage on the trial's outcomes. Overall, the move to the next dose is a significant step forward for Phio Pharmaceuticals in their pursuit of innovative cancer treatments.
https://store.livarava.com/18cb8a55-1d2a-11ef-a3dc-9d5fa15a64d8.jpg
Phio Pharmaceuticals Advances in Cancer Trial and Increases Dose

Phio Pharmaceuticals progresses in cancer trial

The latest announcement from Phio Pharmaceuticals indicates a significant step forward in their cancer trial.

Advancement to next dose level

  • The company has made progress by moving to the next dose level in the trial.

This development marks a crucial stage in the study and raises expectations for the potential outcomes.

Do you want to advertise here? Contact us
Do you want to advertise here? Contact us
Newsletter

We carefully select news from the world of finance and publish it for our users. We understand the importance of reliable and up-to-date information for people in the financial world. Do you want to receive news in a convenient format and always have it at hand — subscribe to our newsletter and make your analytical work more effective.

Subscribe